Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7302
    +0.0005 (+0.06%)
     

  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     

  • Bitcoin CAD

    88,107.64
    -3,156.33 (-3.46%)
     

  • CMC Crypto 200

    1,391.01
    -33.09 (-2.32%)
     

  • GOLD FUTURES

    2,323.10
    -15.30 (-0.65%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,459.75
    -204.75 (-1.16%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,718.25
    -741.83 (-1.93%)
     

  • CAD/EUR

    0.6819
    0.0000 (0.00%)
     

Today’s Research on DCTH, AKRX, ASTX, BMRN, and FRX

ACCESSWIRE

StockCall.com Provides Stock Research on Delcath Systems Inc., Akorn Inc., Astex Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., and Forest Laboratories Inc.

New York City, New York -- (May 10, 2013)

According IMS Institute of Healthcare Informatics, U.S. spending on medicines fell 1% in 2012, the first ever drop since IMS began tracking the data in 1957. The decline was mainly due to expiration of patents on several blockbuster drugs which led to increasing generic competition. Apart from rising generic competition, another major development in the healthcare sector in recent years has been the Affordable Care Act (ACA), which is the biggest overhaul of the industry in decades. These developments have created significant challenges for the healthcare sector. On Thursday, healthcare stocks ended mostly lower, tracking losses in the broad market. Among the major movers were Delcath Systems Inc. (NASDAQ:DCTH - News), Akorn Inc.(NASDAQ:AKRX - News), Astex Pharmaceuticals Inc. (NASDAQ:ASTX - News), BioMarin Pharmaceutical Inc.(NASDAQ:BMRN - News), and Forest Laboratories Inc. (NYSE:FRX - News). StockCall professionals have completed their technical analysis on DCTH, AKRX, ASTX, BMRN, and FRX and these free reports are accessible by registering at

www.stockcall.com/research

ADVERTISEMENT

Delcath Systems Inc.’s shares tumbled in Thursday’s trading session. The stock ended the day 13.27% lower at $0.425 on above average volume of 4.02 million after trading between $0.42 and $0.47. The company’s shares are trading well below their 50-day and 200-day moving averages as a result of yesterday’s sell-off. The stock has now fallen more than 65.40% in 2013 as compared to a gain of over 14% for the S&P 500. Delcath Systems’ shares currently have support at around $0.40. Sign up for the free technical research on DCTH at

www.StockCall.com/DCTH051013.pdf

Shares of Astex Pharmaceuticals Inc. rallied in yesterday’s trading session. The stock finished the day 4.56% higher at $5.50 on volume of 2.02 million after trading between $5.16 and $5.54. Despite the rally on Thursday, Astex’s shares have fallen more than 5.30% in the last three trading sessions. However, year-to-date, the stock is up 89%, easily outperforming the broad market. Be sure to read our latest technical research on AKRX by registering at

www.StockCall.com/AKRX051013.pdf

Shares of Astex Pharmaceuticals Inc. rallied in yesterday’s trading session. The stock finished the day 4.56% higher at $5.50 on volume of 2.02 million after trading between $5.16 and $5.54. Despite the rally on Thursday, Astex’s shares have fallen more than 5.30% in the last three trading sessions. However, year-to-date, the stock is up 89%, easily outperforming the broad market. Sign up and read the complimentary report on ASTX at

www.StockCall.com/ASTX051013.pdf

Shares of BioMarin Pharmaceutical Inc. edged higher in trading on Thursday even as the broad market struggled. The stock touched an intraday high of $66.72 before finishing the day 1.67% higher at $66.41 on above average volume of 1.16 million. BioMarin’s shares are currently trading close to their 52-week high of $67.96. The stock has had an excellent run so far in 2013, gaining nearly 35%. However, the stock’s MACD chart suggests that market sentiment has turned bearish. The free report on BMRN can be downloaded by signing up now at

www.StockCall.com/BMRN051013.pdf

Shares of Forest Laboratories Inc. edged higher in yesterday’s trading session, extending their gains from previous session. The stock closed 0.69% higher at $37.96 on volume of 940,177, taking its growth in the last three sessions to over 2%. Forest Laboratories’ shares are currently trading close to their 52-week high of $38.45. The stock has gained nearly 7.50% so far in 2013, underperforming the S&P 500. Free report on FRX can be accessed by registering at

www.StockCall.com/FRX051013.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)